Login / Signup

Consent for participating in clinical trials - Is it really informed?

Teodora Alexa-StratulatMarius NeaguAnca-Iulia NeaguIoana Dana AlexaBeatrice Gabriela Ioan
Published in: Developing world bioethics (2018)
The article explores the challenges of ensuring voluntary and informed consent which is obtained from potential research subjects in the north-eastern part of Romania. This study is one of the first empirical papers of this nature in Romania. The study used a quantitative survey design using the adapted Quality of Informed Consent (QuIC) questionnaire. The target population consisted of 100 adult persons who voluntarily enrolled in clinical trials. The informed consent form must contain details regarding the potential risks and benefits, the aim of the clinical trial, study design, confidentiality, insurance and contact details in case of additional questions. Our study confirmed that although all required information was included in the ICF, few clinical trial participants truly understood it. We also found that the most important predictive factor for a good subjective and objective understanding of the clinical trial was the level of education. Our study suggests that researchers should consider putting more effort in order to help clinical trials participants achieve a better understanding of the informed consent. In this way they will ensure that participants' decision-making is meaningful and that their interests are protected.
Keyphrases
  • clinical trial
  • phase ii
  • decision making
  • open label
  • double blind
  • high resolution
  • cross sectional
  • phase iii
  • depressive symptoms
  • risk assessment
  • health information